AMP² Innovation by Azurite Health
Amplification of community voices. Medicine with purpose. People at the centre. Squared for real-world, global impact.
Transforming Health Equity Through Community-Led Research & Innovation
AMP² Innovation focuses on the health needs of underserved communities, Africa and the African diaspora, with emphasis on mental health, maternal and child health, oncology, antimicrobial resistance (AMR), and public health innovation.
Our work extends to underserved communities in the UK, United States, and across the global diaspora
We address structural and systemic barriers to care by advancing early intervention models, data equity, lived experience leadership, and community-led research across the continuum of prevention, diagnosis, and care.
AMP² designs and implements research-driven, community-led programmes that bridge clinical research, health systems, and lived experience — creating solutions that are scalable, sustainable, and grounded in the realities of those they serve.
About the Name
The AMP² name reflects our original scientific focus:
Advancing Models for Prediction & Prevention — a foundation we continue to build on through inclusive, community-driven health innovation.
From risk modelling in mental health to early intervention frameworks in maternal care and AMR, AMP² brings together prediction, prevention, and lived experience to redesign systems that work for everyone.
Collaborating Across Borders
We co-create with partners through the ACREDA network, advancing data equity, shared learning, and local ownership of innovation across the UK, Africa, the Caribbean, the United States, and the wider African diaspora.
Join Us
If you're a researcher, community leader, health provider, or funder passionate about equity, prevention, and innovation — we’d love to collaborate.
We don’t just collaborate — we co-create.
AMP² Innovation works in deep partnership with communities, clinicians, and researchers across the UK, Africa, the Caribbean, the U.S., and the global diaspora — building trust, advancing equity, and turning insight into impact.
We power social impact programmes and serve as the home of ACREDA, Azurite Health’s initiative to advance equitable, community-led research across Africa and beyond.
What We Do
- Design culturally grounded models
We co-create early intervention, relapse-prevention, and risk prediction frameworks for mental health and other urgent public health challenges. - Lead community-driven clinical research
Across mental health, maternal and child health, oncology, antimicrobial resistance, and other high-impact areas. - Build digital tools and health education programmes
Designed for real-world use in LMICs and diaspora communities — grounded in culture, language, and lived experience. - Advance data equity
We integrate diverse datasets and amplify underrepresented voices to drive more inclusive research and policy. - Shape policy, public engagement, and cross-border capacity-building
Turning local insight into global influence through training, advocacy, and partnerships.
Launched in 2025, AMP² Innovation builds on five years of Azurite Health’s work in inclusive clinical research — created to scale that mission into social impact, systems change, and global collaboration.
AMP² Innovation is a Community Interest Company (CIC) registered in England and Wales. Company No: 16447149
© Azurite Health Ltd. All rights reserved.
AMP² Innovation is a company owned by Azurite Health Ltd. No part of this site or its content may be reproduced, stored, or transmitted in any form without prior written permission from Azurite Health Ltd.